Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Endokrynologia Polska|March 4, 2017
Epidemiology of gastroenteropancreatic neuroendocrine neoplasms in Krakow and Krakow district in 2007-2011Małgorzata Trofimiuk-Müldner, Ewelina Lewkowicz, Katarzyna Wysocka, et al.
Polskie Archiwum Medycyny Wewnetrznej|April 30, 2015
Gastroenteropancreatic neuroendocrine neoplasms: a 10-year experience of a single centerEwelina Lewkowicz, Małgorzata Trofimiuk-Müldner, Katarzyna Wysocka, et al.
Endokrynologia Polska|January 27, 2023
A patient with advanced breast cancer and hyperthyroidism associated with struma ovariiMagdalena Kamińska, Grzegorz Sokołowski, Kamila Mitka, et al.
Clinical Imaging|June 26, 2012
Are RECIST criteria sufficient to assess response to therapy in neuroendocrine tumors?Anna Sowa-Staszczak, Robert Chrzan, Dorota Pach, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 12, 2011
Peptide receptor radionuclide therapy as a potential tool for neoadjuvant therapy in patients with inoperable neuroendocrine tumours (NETs)Anna Sowa-Staszczak, Dorota Pach, Robert Chrzan, et al.
Postepy Higieny I Medycyny Doswiadczalnej (Online)|February 29, 2012
Dietary patterns as risk factors of differentiated thyroid carcinomaElwira Przybylik-Mazurek, Alicja Hubalewska-Dydejczyk, Sylwia Kuźniarz-Rymarz, et al.
Polskie Archiwum Medycyny Wewnetrznej|December 7, 2011
Positive family history of thyroid disease as a risk factor for differentiated thyroid carcinomaElwira Przybylik-Mazurek, Dorota Pach, Sylwia Kuźniarz-Rymarz, et al.
Endokrynologia Polska|January 11, 2018
Temozolomide therapy for aggressive pituitary Crooke's cell corticotropinoma causing Cushing's Disease - a case report with literature reviewAleksandra Gilis-Januszewska, Małgorzata Wilusz, Jacek Pantofliński, et al.
Endokrynologia Polska|September 2, 2015
Noninsulinoma pancreatogenous hypoglycaemia in adults--a spotlight on its geneticsAleksandra Gilis-Januszewska, Jakub Piątkowski, Anna Skalniak, et al.
Nuclear Medicine Review. Central & Eastern Europe|January 6, 2012
Can treatment using radiolabelled somatostatin analogue increase the survival rate in patients with non-functioning neuroendocrine pancreatic tumours?Anna Sowa-Staszczak, Dorota Pach, Agnieszka Stefańska, et al.
Pageof 8